Blog Tag
2 articles tagged with Patent Cliff. The newest post is from Mar 3, 2026.
An exclusivity period is a time during which a drug is protected from certain forms of competition after approval. In biotech, exclusivity matters because it gives the company time to commercialize the product without immediate copycat competition. That protection is one of the key reasons innovative drugs can generate meaningful revenue after launch.
A patent cliff is the point at which a drug loses patent protection or market exclusivity and faces sharp competition from generic or biosimilar alternatives. In biotech and pharma, the patent cliff matters because it can cause a large drop in revenue when competitors enter the market. Investors watch it closely because it can dramatically change future earnings expectations.
